• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阻断检查点 ILT3/LILRB4/gp49B 与纤维连接蛋白的结合可改善 BXSB/Yaa 小鼠的自身免疫性疾病。

Blockade of checkpoint ILT3/LILRB4/gp49B binding to fibronectin ameliorates autoimmune disease in BXSB/Yaa mice.

机构信息

Department of Experimental Immunology, Institute of Development, Aging and Cancer, Tohoku University, Sendai 980-8575, Japan.

Advanced Preventive Medical Sciences Research Center, Kanazawa University, Kanazawa 920-8640, Japan.

出版信息

Int Immunol. 2021 Jul 23;33(8):447-458. doi: 10.1093/intimm/dxab028.

DOI:10.1093/intimm/dxab028
PMID:34089617
Abstract

The extracellular matrix (ECM) is the basis for virtually all cellular processes and is also related to tumor metastasis. Fibronectin (FN), a major ECM macromolecule expressed by different cell types and also present in plasma, consists of multiple functional modules that bind to ECM-associated, plasma, and cell-surface proteins such as integrins and FN itself, thus ensuring its cell-adhesive and modulatory role. Here we show that FN constitutes an immune checkpoint. Thus, FN was identified as a physiological ligand for a tumor/leukemia/lymphoma- as well as autoimmune-associated checkpoint, ILT3/LILRB4 (B4, CD85k). Human B4 and the murine ortholog, gp49B, bound FN with sub-micromolar affinities as assessed by bio-layer interferometry. The major B4-binding site in FN was located at the N-terminal 30-kDa module (FN30), which is apart from the major integrin-binding site present at the middle of the molecule. Blockade of B4-FN binding such as with B4 antibodies or a recombinant FN30-Fc fusion protein paradoxically ameliorated autoimmune disease in lupus-prone BXSB/Yaa mice. The unexpected nature of the B4-FN checkpoint in autoimmunity is discussed, referring to its potential role in tumor immunity.

摘要

细胞外基质 (ECM) 是几乎所有细胞过程的基础,也与肿瘤转移有关。纤连蛋白 (FN) 是一种主要的 ECM 大分子,不同类型的细胞都会表达,也存在于血浆中,它由多个功能模块组成,这些功能模块与 ECM 相关蛋白、血浆蛋白和细胞表面蛋白(如整合素和 FN 自身)结合,从而确保其具有细胞黏附性和调节作用。在这里,我们表明 FN 构成了一个免疫检查点。因此,FN 被鉴定为肿瘤/白血病/淋巴瘤以及自身免疫相关检查点、ILT3/LILRB4(B4、CD85k)的生理配体。通过生物层干涉测量法评估,人 B4 和鼠同源物 gp49B 以亚微摩尔亲和力结合 FN。FN 中的主要 B4 结合位点位于 N 端 30kDa 模块 (FN30),该位点与分子中部的主要整合素结合位点分开。B4 抗体或重组 FN30-Fc 融合蛋白阻断 B4-FN 结合,例如在狼疮易感 BXSB/Yaa 小鼠中反而改善了自身免疫性疾病。讨论了 B4-FN 检查点在自身免疫中的意外性质,涉及它在肿瘤免疫中的潜在作用。

相似文献

1
Blockade of checkpoint ILT3/LILRB4/gp49B binding to fibronectin ameliorates autoimmune disease in BXSB/Yaa mice.阻断检查点 ILT3/LILRB4/gp49B 与纤维连接蛋白的结合可改善 BXSB/Yaa 小鼠的自身免疫性疾病。
Int Immunol. 2021 Jul 23;33(8):447-458. doi: 10.1093/intimm/dxab028.
2
Myeloid immune checkpoint ILT3/LILRB4/gp49B can co-tether fibronectin with integrin on macrophages.髓系免疫检查点 ILT3/LILRB4/gp49B 可与巨噬细胞上的整合素共同锚定纤维连接蛋白。
Int Immunol. 2022 Jul 26;34(8):435-444. doi: 10.1093/intimm/dxac023.
3
Co-localization of Fibronectin Receptors LILRB4/gp49B and Integrin on Dendritic Cell Surface.纤维连接蛋白受体 LILRB4/gp49B 和整合素在树突状细胞表面的共定位。
Tohoku J Exp Med. 2022 Jun 25;257(3):171-180. doi: 10.1620/tjem.2022.J014. Epub 2022 Jun 10.
4
Fibronectin on target cells attenuates natural cytotoxicity of NK cells via myeloid immune checkpoint ILT3/LILRB4/gp49B.靶细胞上的纤连蛋白通过髓系免疫检查点ILT3/LILRB4/gp49B减弱自然杀伤细胞的自然细胞毒性。
Int Immunol. 2023 Jul 7;35(7):339-348. doi: 10.1093/intimm/dxad012.
5
Gp49B is a pathogenic marker for auto-antibody-producing plasma cells in lupus-prone BXSB/Yaa mice.Gp49B 是狼疮易感 BXSB/Yaa 小鼠中产生自身抗体的浆细胞的致病标志物。
Int Immunol. 2019 May 21;31(6):397-406. doi: 10.1093/intimm/dxz017.
6
The Fibronectin-ILT3 Interaction Functions as a Stromal Checkpoint that Suppresses Myeloid Cells.纤维连接蛋白-ILT3 相互作用作为一种基质检查点,抑制髓系细胞。
Cancer Immunol Res. 2021 Nov;9(11):1283-1297. doi: 10.1158/2326-6066.CIR-21-0240. Epub 2021 Aug 23.
7
LILRB4/gp49B Co-Localizes with Integrin via Fibronectin at Focal Adhesion Sites on Mast Cells.LILRB4/gp49B通过纤连蛋白在肥大细胞的粘着斑部位与整合素共定位。
Tohoku J Exp Med. 2023 Mar 10;259(4):273-284. doi: 10.1620/tjem.2023.J001. Epub 2023 Jan 13.
8
Distribution of integrins on human peripheral blood mononuclear cells.
Blood. 1989 Sep;74(4):1348-54.
9
NK cells require immune checkpoint receptor LILRB4/gp49B to control neurotropic Zika virus infections in mice.自然杀伤细胞需要免疫检查点受体 LILRB4/gp49B 来控制小鼠的神经嗜性寨卡病毒感染。
JCI Insight. 2022 Feb 8;7(3):e151420. doi: 10.1172/jci.insight.151420.
10
ILT3 (LILRB4) Promotes the Immunosuppressive Function of Tumor-Educated Human Monocytic Myeloid-Derived Suppressor Cells.ILT3(LILRB4)促进肿瘤诱导的人单核细胞髓系来源抑制性细胞的免疫抑制功能。
Mol Cancer Res. 2021 Apr;19(4):702-716. doi: 10.1158/1541-7786.MCR-20-0622. Epub 2020 Dec 28.

引用本文的文献

1
Inhibitory leukocyte immunoglobulin-like receptors, subfamily B (LILRBs) in human diseases: structure, roles, mechanisms, and clinical applications.人类疾病中的抑制性白细胞免疫球蛋白样受体B亚家族(LILRBs):结构、作用、机制及临床应用
Theranostics. 2025 Jul 25;15(16):8222-8258. doi: 10.7150/thno.116951. eCollection 2025.
2
Secretogranin 2 binds LILRB4 resulting in immunosuppression.嗜铬粒蛋白2与白细胞免疫球蛋白样受体B4结合,导致免疫抑制。
Nat Immunol. 2025 Jul 24. doi: 10.1038/s41590-025-02233-4.
3
Multiple Myeloma Cells with Increased Proteasomal and ER Stress Are Hypersensitive to ATX-101, an Experimental Peptide Drug Targeting PCNA.
蛋白酶体和内质网应激增加的多发性骨髓瘤细胞对ATX-101(一种靶向增殖细胞核抗原的实验性肽药物)高度敏感。
Cancers (Basel). 2024 Nov 26;16(23):3963. doi: 10.3390/cancers16233963.
4
Leukocyte immunoglobulin-like receptor B4: A keystone in immune modulation and therapeutic target in cancer and beyond.白细胞免疫球蛋白样受体B4:免疫调节的关键因子及癌症等疾病的治疗靶点
Cancer Innov. 2024 Oct 22;3(6):e153. doi: 10.1002/cai2.153. eCollection 2024 Dec.
5
Purinergic exposure induces epigenomic and transcriptomic-mediated preconditioning resembling epilepsy-associated microglial states.嘌呤能暴露诱导表观基因组和转录组介导的预处理,类似于癫痫相关的小胶质细胞状态。
iScience. 2024 Jul 20;27(8):110546. doi: 10.1016/j.isci.2024.110546. eCollection 2024 Aug 16.
6
LILRB4 Checkpoint for Immunotherapy: Structure, Mechanism and Disease Targets.LILRB4 免疫疗法检查点:结构、机制和疾病靶点。
Biomolecules. 2024 Feb 4;14(2):187. doi: 10.3390/biom14020187.
7
Human leukocyte immunoglobulin-like receptors in health and disease.人类白细胞免疫球蛋白样受体在健康与疾病中的作用。
Front Immunol. 2023 Nov 13;14:1282874. doi: 10.3389/fimmu.2023.1282874. eCollection 2023.
8
Prognostic impact of LILRB4 expression on tumor-infiltrating cells in resected non-small cell lung cancer.LILRB4 表达对切除的非小细胞肺癌肿瘤浸润细胞的预后影响。
Thorac Cancer. 2023 Jul;14(21):2057-2068. doi: 10.1111/1759-7714.14991. Epub 2023 Jun 8.
9
Antibody therapies for the treatment of acute myeloid leukemia: exploring current and emerging therapeutic targets.用于治疗急性髓系白血病的抗体疗法:探索当前和新兴的治疗靶点。
Expert Opin Investig Drugs. 2023 Feb;32(2):107-125. doi: 10.1080/13543784.2023.2179482. Epub 2023 Feb 26.
10
LILRB4, an immune checkpoint on myeloid cells.LILRB4,一种髓系细胞上的免疫检查点。
Blood Sci. 2022 May 17;4(2):49-56. doi: 10.1097/BS9.0000000000000109. eCollection 2022 Apr.